NCT02113293View on ClinicalTrials.gov

CyclASol® Phase 1 Study

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Healthy

Interventions

DRUG

CyclASol®

Cyclosporine A Solution

DRUG

Placebo (vehicle)

Vehicle Solution

Trial Locations (1)

89231

Neu-Ulm

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novaliq GmbH

INDUSTRY

NCT02113293 - CyclASol® Phase 1 Study | Biotech Hunter | Biotech Hunter